Ruth F Dubin1, Rajat Deo2, Nisha Bansal3, Amanda H Anderson2, Peter Yang2, Alan S Go4, Martin Keane5, Ray Townsend2, Anna Porter6, Matthew Budoff7, Shaista Malik5, Jiang He8, Mahboob Rahman9, Jackson Wright9, Thomas Cappola2, Radhakrishna Kallem2, Jason Roy2, Daohang Sha2, Michael G Shlipak10. 1. University of California, San Francisco/San Francisco Veterans Affairs Medical Center, San Francisco, California; ruth.dubin@ucsf.edu. 2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 3. University of Washington, Seattle, Washington. 4. Division of Clinical Research, Kaiser Permanente, Oakland, California. 5. Temple University Hospital, Philadelphia, Pennsylvania. 6. University of California, Irvine, California. 7. University of California, Los Angeles, California. 8. Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana; and. 9. University Hospitals Case Medical Center, Cleveland, Ohio. 10. University of California, San Francisco/San Francisco Veterans Affairs Medical Center, San Francisco, California.
Abstract
BACKGROUND AND OBJECTIVES: Heart failure is the most frequent cardiac complication of CKD. Left ventricular hypertrophy is common and develops early in CKD, but studies have not adequately evaluated the association of left ventricular mass index with heart failure incidence among men and women with CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We evaluated echocardiograms of 2567 participants without self-reported heart failure enrolled in the Chronic Renal Insufficiency Cohort Study. Two-dimensional echocardiograms were performed at the year 1 study visit and interpreted at a central core laboratory. Left ventricular mass index was calculated using the linear method, indexed to height2.7, and analyzed using sex-specific quartiles. The primary outcomes of incident heart failure and all-cause mortality were adjudicated over a median of 6.6 (interquartile range, 5.7-7.6) years. RESULTS: Among 2567 participants, 45% were women, and 54% were nonwhite race; mean (SD) age was 59±11 years old, and mean eGFR was 44±17 ml/min per 1.73 m2. During a median follow-up period of 6.6 years, 262 participants developed heart failure, and 470 participants died. Compared with participants in the first quartile of left ventricular mass index, those in the highest quartile had higher rates of incident heart failure (hazard ratio, 3.96; 95% confidence interval, 1.96 to 8.02) and mortality (hazard ratio, 1.86; 95% confidence interval, 1.22 to 2.85), even after adjustment for B-type natriuretic peptide, troponin T, mineral metabolism markers, and other cardiovascular disease risk factors. Those in the lowest quartile of ejection fraction had higher rates of incident heart failure (hazard ratio, 3.01; 95% confidence interval, 1.94 to 4.67) but similar mortality rates (hazard ratio, 1.18; 95% confidence interval, 0.89 to 1.57) compared with those in the highest quartile. Diastolic dysfunction was not significantly associated with heart failure or death. CONCLUSIONS: Among persons with CKD and without history of cardiovascular disease, left ventricular mass index is strongly associated with incident heart failure, even after adjustment for major cardiovascular risk factors and biomarkers.
BACKGROUND AND OBJECTIVES:Heart failure is the most frequent cardiac complication of CKD. Left ventricular hypertrophy is common and develops early in CKD, but studies have not adequately evaluated the association of left ventricular mass index with heart failure incidence among men and women with CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We evaluated echocardiograms of 2567 participants without self-reported heart failure enrolled in the Chronic Renal Insufficiency Cohort Study. Two-dimensional echocardiograms were performed at the year 1 study visit and interpreted at a central core laboratory. Left ventricular mass index was calculated using the linear method, indexed to height2.7, and analyzed using sex-specific quartiles. The primary outcomes of incident heart failure and all-cause mortality were adjudicated over a median of 6.6 (interquartile range, 5.7-7.6) years. RESULTS: Among 2567 participants, 45% were women, and 54% were nonwhite race; mean (SD) age was 59±11 years old, and mean eGFR was 44±17 ml/min per 1.73 m2. During a median follow-up period of 6.6 years, 262 participants developed heart failure, and 470 participants died. Compared with participants in the first quartile of left ventricular mass index, those in the highest quartile had higher rates of incident heart failure (hazard ratio, 3.96; 95% confidence interval, 1.96 to 8.02) and mortality (hazard ratio, 1.86; 95% confidence interval, 1.22 to 2.85), even after adjustment for B-type natriuretic peptide, troponin T, mineral metabolism markers, and other cardiovascular disease risk factors. Those in the lowest quartile of ejection fraction had higher rates of incident heart failure (hazard ratio, 3.01; 95% confidence interval, 1.94 to 4.67) but similar mortality rates (hazard ratio, 1.18; 95% confidence interval, 0.89 to 1.57) compared with those in the highest quartile. Diastolic dysfunction was not significantly associated with heart failure or death. CONCLUSIONS: Among persons with CKD and without history of cardiovascular disease, left ventricular mass index is strongly associated with incident heart failure, even after adjustment for major cardiovascular risk factors and biomarkers.
Authors: Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista Journal: J Am Soc Echocardiogr Date: 2009-02 Impact factor: 5.251
Authors: Tamara Isakova; Huiliang Xie; Wei Yang; Dawei Xie; Amanda Hyre Anderson; Julia Scialla; Patricia Wahl; Orlando M Gutiérrez; Susan Steigerwalt; Jiang He; Stanley Schwartz; Joan Lo; Akinlolu Ojo; James Sondheimer; Chi-yuan Hsu; James Lash; Mary Leonard; John W Kusek; Harold I Feldman; Myles Wolf Journal: JAMA Date: 2011-06-15 Impact factor: 56.272
Authors: Rathika Krishnasamy; Nicole M Isbel; Carmel M Hawley; Elaine M Pascoe; Rodel Leano; Brian A Haluska; Tony Stanton Journal: Nephrol Dial Transplant Date: 2014-02-09 Impact factor: 5.992
Authors: Gail E Peterson; Tine de Backer; Gabriel Contreras; Xuelei Wang; Cynthia Kendrick; Tom Greene; Lawrence J Appel; Otelio S Randall; Janice Lea; Miroslaw Smogorzewski; Tudor Vagaonescu; Robert A Phillips Journal: Hypertension Date: 2013-07-08 Impact factor: 10.190
Authors: Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto Journal: N Engl J Med Date: 2009-10-30 Impact factor: 91.245
Authors: Kunihiro Matsushita; Josef Coresh; Yingying Sang; John Chalmers; Caroline Fox; Eliseo Guallar; Tazeen Jafar; Simerjot K Jassal; Gijs W D Landman; Paul Muntner; Paul Roderick; Toshimi Sairenchi; Ben Schöttker; Anoop Shankar; Michael Shlipak; Marcello Tonelli; Jonathan Townend; Arjan van Zuilen; Kazumasa Yamagishi; Kentaro Yamashita; Ron Gansevoort; Mark Sarnak; David G Warnock; Mark Woodward; Johan Ärnlöv Journal: Lancet Diabetes Endocrinol Date: 2015-05-28 Impact factor: 32.069
Authors: Roland Nnaemeka Okoro; Maxwell Ogochukwu Adibe; Mathew Jegbefume Okonta; Ibrahim Ummate; John David Ohieku; Sani Ibn Yakubu Journal: Int Urol Nephrol Date: 2021-03-26 Impact factor: 2.370
Authors: Nicholas F Lahens; Mahboob Rahman; Jordana B Cohen; Debbie L Cohen; Jing Chen; Matthew R Weir; Harold I Feldman; Gregory R Grant; Raymond R Townsend; Carsten Skarke; And The Cric Study Investigators Journal: Digit Health Date: 2022-06-16
Authors: Paula F Orlandi; Dawei Xie; Wei Yang; Jordana B Cohen; Rajat Deo; Ana C Ricardo; Sarah Schrauben; Xue Wang; L Lee Hamm; Jiang He; James H Sondheimer; Krishna Kallem; Raymond Townsend; Dominic Raj; Afshin Parsa; Amanda H Anderson; Harold I Feldman Journal: J Am Soc Nephrol Date: 2020-10-06 Impact factor: 10.121
Authors: Jesse K Fitzpatrick; Andrew P Ambrosy; Rishi V Parikh; Thida C Tan; Nisha Bansal; Alan S Go Journal: Am Heart J Date: 2022-03-10 Impact factor: 4.749
Authors: Kai-Uwe Eckardt; Nisha Bansal; Josef Coresh; Marie Evans; Morgan E Grams; Charles A Herzog; Matthew T James; Hiddo J L Heerspink; Carol A Pollock; Paul E Stevens; Manjula Kurella Tamura; Marcello A Tonelli; David C Wheeler; Wolfgang C Winkelmayer; Michael Cheung; Brenda R Hemmelgarn Journal: Kidney Int Date: 2018-04-12 Impact factor: 10.612
Authors: Taimur Dad; Kaleab Z Abebe; K Ty Bae; Diane Comer; Vicente E Torres; Peter G Czarnecki; Robert W Schrier; Theodore I Steinman; Charity G Moore; Arlene B Chapman; Diana Kaya; Cheng Tao; William E Braun; Franz T Winklhofer; Godela Brosnahan; Marie C Hogan; Dana C Miskulin; Frederic Rahbari Oskoui; Michael F Flessner; Ronald D Perrone Journal: Kidney Int Rep Date: 2018-01-06
Authors: Ruth F Dubin; Mary Whooley; Alexander Pico; Peter Ganz; Nelson B Schiller; Craig Meyer Journal: PLoS One Date: 2018-12-17 Impact factor: 3.240
Authors: Mark L Unruh; Soraya Arzhan; Harold I Feldman; Helen C Looker; Robert G Nelson; Thomas Faber; David Johnson; Linda Son-Stone; Vernon S Pankratz; Larissa Myaskovsky; Vallabh O Shah Journal: BMC Nephrol Date: 2020-07-22 Impact factor: 2.388
Authors: Tori A Stromp; Tyler J Spear; Rebecca M Holtkamp; Kristin N Andres; Joshua C Kaine; Wissam H Alghuraibawi; Steve W Leung; Brandon K Fornwalt; Moriel H Vandsburger Journal: Sci Rep Date: 2018-11-19 Impact factor: 4.379